Advaxis

From WikiMD's Wellness Encyclopedia

Revision as of 21:57, 11 February 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

American biotechnology company



Advaxis is an American biotechnology company focused on the development of cancer immunotherapies. The company is known for its proprietary Listeria monocytogenes-based antigen delivery platform, which is designed to stimulate the immune system to target and destroy cancer cells.

History

Advaxis was founded in 2002 and is headquartered in Princeton, New Jersey. The company was established to develop and commercialize the innovative research conducted by Dr. Yvonne Paterson at the University of Pennsylvania.

Technology

Advaxis utilizes a unique approach to cancer treatment by employing a live-attenuated strain of the bacterium Listeria monocytogenes to deliver tumor-associated antigens directly to the immune system. This method is intended to enhance the body's natural ability to recognize and attack cancer cells.

Listeria monocytogenes Platform

The Listeria monocytogenes platform is designed to stimulate both the innate and adaptive immune responses. The bacteria are engineered to express specific antigens associated with cancer cells, which are then presented to the immune system, prompting a targeted immune response.

Pipeline

Advaxis has developed several product candidates targeting various types of cancer, including cervical cancer, prostate cancer, and head and neck cancer. These candidates are in various stages of clinical development.

ADXS-HPV

ADXS-HPV is one of Advaxis's lead product candidates, targeting human papillomavirus (HPV)-associated cancers. It is designed to elicit an immune response against HPV-infected cells, which are often precursors to cervical cancer.

ADXS-PSA

ADXS-PSA is being developed for the treatment of prostate cancer. It targets the prostate-specific antigen (PSA), a protein produced by both normal and malignant prostate cells.

ADXS-HER2

ADXS-HER2 is aimed at treating HER2-expressing cancers, such as certain types of breast cancer and gastric cancer.

Collaborations

Advaxis has entered into several strategic collaborations with other biotechnology and pharmaceutical companies to advance its pipeline and expand the potential applications of its technology.

See also

Related pages

Gallery

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your life with W8MD's Budget GLP-1 injections from $75


W8MD weight loss doctors team
W8MD weight loss doctors team

W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:

NYC weight loss doctor appointmentsNYC weight loss doctor appointments

Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.

Linkedin_Shiny_Icon Facebook_Shiny_Icon YouTube_icon_(2011-2013) Google plus


Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.